Solventum Corp | SOLV - Operating Expenses

Stock Price
75.33
Daily Change
-1.58 -2.05%
Monthly
-6.77%
Yearly
0.97%
Q1 Forecast
74.60

Solventum Corp reported $4.99B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Align Technology USD 811.05M 38.37M Sep/2025
Baxter International USD 2.63B 95.8M Sep/2025
Becton, Dickinson and Co. USD 5.07B 535M Sep/2025
Cencora USD 82.77B 3.09B Sep/2025
Dexcom USD 966.8M 22.3M Sep/2025
Insulet USD 588.6M 60.6M Sep/2025
Solventum Corp USD 4.99B 3.04B Sep/2025
West Pharmaceutical Services USD 3.05B 2.44B Sep/2025
Zimmer Biomet Holdings USD 1.66B 17.8M Sep/2025